Related Experiment Video
Updated: Aug 26, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
The neurodevelopmental progress of infants less than 33 weeks into adolescence
1Perinatal Brain Research Group, Department of Paediatrics, University College, London, UK. Institute of Psychiatry, King's College, London, UK. f.o'brien@ucl.ac.uk
Insights
Neurodevelopmental impairment worsened in very preterm survivors from age 8 to 15. Cognitive function declined, and more adolescents required extra educational support, indicating potential long-term challenges.
Area of Science:
- Neuroscience
- Developmental Pediatrics
- Public Health
Background:
- Very preterm infants often face neurodevelopmental challenges.
- Previous studies indicate increased impairment at school age.
Purpose of the Study:
- To compare neurodevelopmental outcomes in very preterm survivors at 8 and 15 years of age.
- To assess changes in cognitive function and educational support needs over time.
Main Methods:
- A cohort of 151 very preterm infants (born before 33 weeks gestation) were reassessed at 8 and 15 years.
- Neurodevelopmental function was evaluated using neurological exams, psychometric tests (WISC-R), visuomotor integration (Beery), and school questionnaires.
Main Results:
- The proportion of subjects with disability increased from 11% at 8 years to 22% at 15 years.
- Full scale IQ scores decreased from 104 to 95 between childhood and adolescence.
- Need for extra educational support rose from 15% at 8 years to 24% at 15 years.
Conclusions:
- Very preterm survivors show apparent neurodevelopmental deterioration between ages 8 and 15.
- This may reflect genuine cognitive decline or the manifestation of pre-existing conditions in complex environments.
- Longitudinal follow-up is crucial for understanding the trajectory of neurodevelopmental outcomes in this population.
Background:
Several studies have shown an increased incidence of neurodevelopmental impairment in very preterm survivors at school age compared with controls.
Aim:
To compare findings in the same cohort at 8 years and 15 years.
Methods:
A total of 151 of the 224 eligible infants born before 33 weeks of gestation from 1979 to 1982, and who were living in the UK, were assessed at 8 and 15 years. Items common to both assessments were compared to evaluate changes in neurodevelopmental function. The assessment included a structured neurological examination, psychometric tests using the WISC-R (in subjects born in 1981-82), a test of visuomotor integration (Beery), and a school questionnaire.
Results:
There was a significant increase in the proportion of subjects classified as impaired with disability from 11% at 8 to 22% at 14-15 years of age. The proportion of subjects classified as impaired without disability increased from 16% at 8 to 26% at 14-15 years of age. Full scale IQ decreased from 104 to 95 from childhood to adolescence, and more adolescents (24%) were requiring extra educational provision than they had at the age of 8 years (15%).
Conclusion:
Results indicate that between the ages of 8 and 15 years in this cohort of very preterm survivors there is an apparent deterioration in neurodevelopmental outcome category, cognitive function, and extra educational support. It is not clear whether this represents a genuine deterioration in neurocognitive function or whether it represents the expression of pre-existing cerebral pathology in an increasingly complex environment.
Related Concept Videos
Cognitive Development During Adolescence
Introduction to Developmental Psychology
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Revisionist Views of Adolescent and Adult Cognition
Neurulation
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

